Rockefeller Capital Management
TYRA icon

Rockefeller Capital Management’s Tyra Biosciences TYRA Stock Holding History

Rockefeller Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Hold
421
– – ﹤0.01% 3894
2026
Q1 		$16.1K Buy
421
+337
+401% +$10.9K ﹤0.01% 3796
2025
Q4 		$2.21K Buy
+84
New +$1.54K ﹤0.01% 4297

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Rockefeller Capital Management's TYRA Position: Q2 2026 in Review

Rockefeller Capital Management held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 421 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.

Rockefeller Capital Management first reported a position in TYRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.1K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Rockefeller Capital Management held 421 shares of Tyra Biosciences worth $13.4K as of Q2 2026.
  • Rockefeller Capital Management left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3894 holding.
  • Rockefeller Capital Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Tyra Biosciences position peaked at $16.1K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.